Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genomics | 14 | 2022 | 5828 | 2.290 |
Why?
|
Pathology | 5 | 2018 | 269 | 2.020 |
Why?
|
Pathology, Molecular | 4 | 2021 | 329 | 1.900 |
Why?
|
Blood Transfusion | 13 | 2024 | 1303 | 1.490 |
Why?
|
Internship and Residency | 11 | 2022 | 5885 | 1.220 |
Why?
|
Education, Medical, Graduate | 4 | 2021 | 2374 | 1.060 |
Why?
|
Erythrocyte Transfusion | 5 | 2023 | 569 | 1.060 |
Why?
|
Cord Blood Stem Cell Transplantation | 7 | 2016 | 305 | 1.050 |
Why?
|
Educational Measurement | 5 | 2021 | 1250 | 0.980 |
Why?
|
Erythroblastosis, Fetal | 3 | 2022 | 62 | 0.960 |
Why?
|
Curriculum | 13 | 2022 | 3741 | 0.920 |
Why?
|
Pathology, Clinical | 4 | 2012 | 376 | 0.920 |
Why?
|
Blood Group Antigens | 2 | 2023 | 184 | 0.840 |
Why?
|
Antigens, CD34 | 1 | 2024 | 655 | 0.780 |
Why?
|
Rh-Hr Blood-Group System | 2 | 2015 | 64 | 0.730 |
Why?
|
Blood Grouping and Crossmatching | 4 | 2022 | 100 | 0.720 |
Why?
|
Hemolysis | 1 | 2022 | 415 | 0.710 |
Why?
|
Isoantibodies | 5 | 2022 | 675 | 0.660 |
Why?
|
Blood Banks | 2 | 2010 | 108 | 0.630 |
Why?
|
Hematologic Diseases | 1 | 2022 | 496 | 0.630 |
Why?
|
Physicians | 7 | 2021 | 4584 | 0.590 |
Why?
|
Rho(D) Immune Globulin | 4 | 2022 | 34 | 0.590 |
Why?
|
Medical Oncology | 3 | 2021 | 2320 | 0.580 |
Why?
|
Rh Isoimmunization | 2 | 2015 | 23 | 0.560 |
Why?
|
Hospitalists | 1 | 2021 | 294 | 0.560 |
Why?
|
Problem-Based Learning | 2 | 2018 | 356 | 0.520 |
Why?
|
Fetal Blood | 5 | 2016 | 1348 | 0.520 |
Why?
|
Bone Marrow Transplantation | 1 | 2023 | 2692 | 0.500 |
Why?
|
Hematologic Neoplasms | 2 | 2024 | 1895 | 0.440 |
Why?
|
Graft vs Host Disease | 4 | 2024 | 3025 | 0.420 |
Why?
|
Blood Specimen Collection | 2 | 2016 | 238 | 0.420 |
Why?
|
Clinical Competence | 11 | 2022 | 4788 | 0.410 |
Why?
|
Clinical Audit | 1 | 2011 | 28 | 0.380 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2024 | 5666 | 0.380 |
Why?
|
Education, Medical, Undergraduate | 2 | 2018 | 1072 | 0.370 |
Why?
|
Emergency Medical Services | 1 | 2022 | 1920 | 0.370 |
Why?
|
Plasma Exchange | 1 | 2011 | 159 | 0.360 |
Why?
|
Blood Component Transfusion | 1 | 2011 | 142 | 0.350 |
Why?
|
Erythrocytes | 5 | 2023 | 2413 | 0.350 |
Why?
|
Platelet Transfusion | 3 | 2013 | 298 | 0.350 |
Why?
|
Needs Assessment | 5 | 2021 | 1141 | 0.340 |
Why?
|
Medical Records | 1 | 2015 | 1409 | 0.340 |
Why?
|
Pregnancy Complications | 3 | 2015 | 2949 | 0.320 |
Why?
|
Blood Group Incompatibility | 2 | 2023 | 135 | 0.320 |
Why?
|
Graft Survival | 4 | 2009 | 3843 | 0.300 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3354 | 0.300 |
Why?
|
Laboratories, Hospital | 1 | 2009 | 192 | 0.300 |
Why?
|
Internal Medicine | 1 | 2014 | 1050 | 0.290 |
Why?
|
Boronic Acids | 1 | 2011 | 915 | 0.280 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2008 | 95 | 0.280 |
Why?
|
Humans | 66 | 2024 | 761208 | 0.280 |
Why?
|
Quality Control | 1 | 2010 | 833 | 0.280 |
Why?
|
Vitamin K Deficiency Bleeding | 1 | 2006 | 9 | 0.270 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 1999 | 456 | 0.260 |
Why?
|
Multiple Myeloma | 3 | 2020 | 5145 | 0.250 |
Why?
|
ABO Blood-Group System | 3 | 2023 | 381 | 0.250 |
Why?
|
Pyrazines | 1 | 2011 | 1202 | 0.250 |
Why?
|
Transplantation, Homologous | 3 | 2024 | 4822 | 0.250 |
Why?
|
Computer Simulation | 1 | 2018 | 6224 | 0.240 |
Why?
|
Metalloendopeptidases | 2 | 2014 | 389 | 0.240 |
Why?
|
Trans-Activators | 6 | 2007 | 2846 | 0.240 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2005 | 106 | 0.240 |
Why?
|
Cell Separation | 2 | 2016 | 1721 | 0.230 |
Why?
|
Education | 2 | 2017 | 536 | 0.220 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2005 | 131 | 0.220 |
Why?
|
Blood Transfusion, Intrauterine | 1 | 2022 | 28 | 0.210 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 2022 | 59 | 0.210 |
Why?
|
Hematopoietic Stem Cells | 2 | 2020 | 3388 | 0.210 |
Why?
|
Blood Component Removal | 1 | 2022 | 132 | 0.190 |
Why?
|
von Willebrand Factor | 1 | 2005 | 677 | 0.180 |
Why?
|
Evidence-Based Medicine | 2 | 2010 | 3691 | 0.180 |
Why?
|
Schools, Medical | 2 | 2021 | 878 | 0.180 |
Why?
|
Online Systems | 1 | 2020 | 182 | 0.170 |
Why?
|
Cell Nucleus | 3 | 1999 | 2881 | 0.170 |
Why?
|
Acute Kidney Injury | 1 | 2011 | 1923 | 0.160 |
Why?
|
Review Literature as Topic | 3 | 2011 | 348 | 0.160 |
Why?
|
Education, Medical | 2 | 2010 | 1725 | 0.150 |
Why?
|
Vulnerable Populations | 1 | 2023 | 706 | 0.140 |
Why?
|
Membrane Transport Proteins | 1 | 2023 | 1031 | 0.140 |
Why?
|
DNA-Binding Proteins | 6 | 2004 | 9566 | 0.140 |
Why?
|
Biomedical Research | 2 | 2017 | 3434 | 0.130 |
Why?
|
Antibodies, Monoclonal | 2 | 2015 | 9187 | 0.130 |
Why?
|
Transplantation, Autologous | 1 | 2020 | 2112 | 0.130 |
Why?
|
Preceptorship | 1 | 2016 | 56 | 0.130 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2017 | 296 | 0.130 |
Why?
|
Financing, Organized | 1 | 2017 | 204 | 0.120 |
Why?
|
Models, Educational | 1 | 2018 | 373 | 0.120 |
Why?
|
Data Collection | 2 | 2014 | 3320 | 0.120 |
Why?
|
Fetus | 1 | 2022 | 1864 | 0.120 |
Why?
|
von Willebrand Diseases | 1 | 2017 | 132 | 0.120 |
Why?
|
Kell Blood-Group System | 1 | 2014 | 21 | 0.120 |
Why?
|
Thrombelastography | 1 | 2017 | 187 | 0.120 |
Why?
|
Transplantation Chimera | 2 | 2007 | 594 | 0.120 |
Why?
|
Infant, Newborn | 5 | 2022 | 26199 | 0.120 |
Why?
|
False Negative Reactions | 1 | 2015 | 573 | 0.110 |
Why?
|
Educational Status | 1 | 2021 | 2510 | 0.110 |
Why?
|
Microbiological Techniques | 1 | 2014 | 97 | 0.110 |
Why?
|
Anesthesiology | 1 | 2022 | 1122 | 0.100 |
Why?
|
Blood Preservation | 1 | 2013 | 169 | 0.100 |
Why?
|
Hematology | 1 | 2015 | 243 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2014 | 3634 | 0.100 |
Why?
|
Anesthesia | 1 | 2022 | 1591 | 0.090 |
Why?
|
Australia | 1 | 2014 | 1246 | 0.090 |
Why?
|
Antineoplastic Agents | 2 | 2011 | 13632 | 0.090 |
Why?
|
Pregnancy | 4 | 2022 | 29893 | 0.090 |
Why?
|
Genome, Human | 2 | 2014 | 4423 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2015 | 825 | 0.090 |
Why?
|
Histocompatibility Testing | 2 | 2009 | 716 | 0.090 |
Why?
|
Delphi Technique | 1 | 2013 | 848 | 0.080 |
Why?
|
Canada | 1 | 2014 | 2125 | 0.080 |
Why?
|
United States | 6 | 2022 | 72339 | 0.080 |
Why?
|
Kruppel-Like Transcription Factors | 3 | 2007 | 504 | 0.080 |
Why?
|
STAT1 Transcription Factor | 3 | 1999 | 340 | 0.080 |
Why?
|
Biostatistics | 1 | 2010 | 164 | 0.080 |
Why?
|
Vanadates | 2 | 1999 | 82 | 0.080 |
Why?
|
Quality Assurance, Health Care | 2 | 2017 | 2164 | 0.080 |
Why?
|
Epitopes | 1 | 2015 | 2504 | 0.080 |
Why?
|
Europe | 1 | 2014 | 3423 | 0.070 |
Why?
|
Histocompatibility | 1 | 2009 | 319 | 0.070 |
Why?
|
Macrocyclic Compounds | 1 | 2007 | 68 | 0.070 |
Why?
|
Coronary Artery Bypass | 1 | 2017 | 2193 | 0.070 |
Why?
|
Coloring Agents | 1 | 2010 | 561 | 0.070 |
Why?
|
Receptors, Complement 3b | 1 | 2007 | 136 | 0.070 |
Why?
|
Erythroblasts | 1 | 2007 | 142 | 0.070 |
Why?
|
Program Evaluation | 1 | 2016 | 2489 | 0.070 |
Why?
|
Staurosporine | 2 | 1999 | 241 | 0.070 |
Why?
|
Plasma | 1 | 2010 | 586 | 0.070 |
Why?
|
Blood Cells | 1 | 2008 | 306 | 0.070 |
Why?
|
Students, Medical | 2 | 2018 | 1940 | 0.070 |
Why?
|
Learning | 1 | 2016 | 1737 | 0.070 |
Why?
|
Plasmapheresis | 1 | 2007 | 207 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2021 | 4014 | 0.070 |
Why?
|
Pediatrics | 1 | 2021 | 3590 | 0.060 |
Why?
|
Immunoglobulin Light Chains | 1 | 2007 | 286 | 0.060 |
Why?
|
Female | 14 | 2024 | 392544 | 0.060 |
Why?
|
Medical Order Entry Systems | 1 | 2011 | 521 | 0.060 |
Why?
|
Adult | 10 | 2024 | 221119 | 0.060 |
Why?
|
Germ-Line Mutation | 1 | 2014 | 1852 | 0.060 |
Why?
|
Training Support | 1 | 2006 | 108 | 0.060 |
Why?
|
Mycophenolic Acid | 1 | 2007 | 350 | 0.060 |
Why?
|
Resource Allocation | 1 | 2008 | 350 | 0.060 |
Why?
|
Attitude | 1 | 2010 | 771 | 0.060 |
Why?
|
Myeloablative Agonists | 1 | 2006 | 209 | 0.060 |
Why?
|
Cardiology | 1 | 2016 | 1693 | 0.060 |
Why?
|
Chimerism | 1 | 2006 | 155 | 0.060 |
Why?
|
Young Adult | 6 | 2024 | 59221 | 0.060 |
Why?
|
Retrospective Studies | 6 | 2024 | 80674 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2014 | 7400 | 0.060 |
Why?
|
Bone Marrow Cells | 2 | 2008 | 2410 | 0.060 |
Why?
|
Transplantation Conditioning | 2 | 2010 | 1591 | 0.060 |
Why?
|
Alleles | 1 | 2015 | 6857 | 0.060 |
Why?
|
ADAM Proteins | 1 | 2005 | 238 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4739 | 0.050 |
Why?
|
Evidence-Based Practice | 1 | 2008 | 493 | 0.050 |
Why?
|
Publishing | 1 | 2010 | 832 | 0.050 |
Why?
|
Boston | 2 | 2014 | 9327 | 0.050 |
Why?
|
Immunoglobulin G | 1 | 2015 | 4537 | 0.050 |
Why?
|
Male | 12 | 2024 | 360693 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2006 | 793 | 0.050 |
Why?
|
Middle Aged | 10 | 2024 | 220853 | 0.050 |
Why?
|
Antigens | 1 | 2007 | 1441 | 0.050 |
Why?
|
Chemokine CCL2 | 1 | 2004 | 602 | 0.050 |
Why?
|
Thromboembolism | 1 | 2008 | 992 | 0.050 |
Why?
|
Gram-Negative Bacteria | 1 | 2023 | 271 | 0.050 |
Why?
|
Renal Insufficiency | 1 | 2007 | 808 | 0.050 |
Why?
|
Prevalence | 2 | 2015 | 15721 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3885 | 0.050 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2002 | 436 | 0.040 |
Why?
|
Adolescent | 3 | 2024 | 88298 | 0.040 |
Why?
|
Genotype | 1 | 2015 | 12985 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2002 | 1681 | 0.040 |
Why?
|
Aged | 6 | 2024 | 169288 | 0.040 |
Why?
|
Vasculitis | 1 | 2004 | 522 | 0.040 |
Why?
|
Interferon-gamma | 2 | 1999 | 3155 | 0.040 |
Why?
|
Career Choice | 1 | 2006 | 757 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8519 | 0.040 |
Why?
|
Phosphorylation | 3 | 1999 | 8300 | 0.040 |
Why?
|
Transfection | 3 | 2004 | 5748 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 856 | 0.040 |
Why?
|
Monocytes | 1 | 2007 | 2570 | 0.040 |
Why?
|
Muscle Proteins | 1 | 2002 | 1149 | 0.030 |
Why?
|
Leupeptins | 1 | 1996 | 112 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2015 | 58952 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 2091 | 0.030 |
Why?
|
Receptors, Interferon | 1 | 1996 | 115 | 0.030 |
Why?
|
Gene Expression Regulation | 3 | 2004 | 11856 | 0.030 |
Why?
|
Phosphotyrosine | 1 | 1996 | 455 | 0.030 |
Why?
|
Cell Division | 1 | 2023 | 4451 | 0.030 |
Why?
|
Acetylcysteine | 1 | 1996 | 260 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 4190 | 0.030 |
Why?
|
Cell Line | 4 | 2004 | 15545 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2010 | 10218 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1728 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 1996 | 551 | 0.030 |
Why?
|
Adipose Tissue | 2 | 2002 | 3313 | 0.030 |
Why?
|
Plateletpheresis | 1 | 2013 | 38 | 0.030 |
Why?
|
Multienzyme Complexes | 1 | 1996 | 665 | 0.030 |
Why?
|
Uterine Hemorrhage | 1 | 2014 | 240 | 0.030 |
Why?
|
Transcription Factors | 2 | 2002 | 12099 | 0.030 |
Why?
|
Transcription, Genetic | 3 | 2004 | 7571 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 2 | 2002 | 130 | 0.020 |
Why?
|
Organizational Policy | 1 | 2014 | 431 | 0.020 |
Why?
|
Time Factors | 3 | 2013 | 39957 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 8003 | 0.020 |
Why?
|
Kinetics | 1 | 1999 | 6312 | 0.020 |
Why?
|
Cryopreservation | 1 | 2016 | 728 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2002 | 2974 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2007 | 15308 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2016 | 803 | 0.020 |
Why?
|
Unnecessary Procedures | 1 | 2014 | 418 | 0.020 |
Why?
|
Escherichia coli | 1 | 2023 | 4201 | 0.020 |
Why?
|
Algorithms | 1 | 2011 | 14025 | 0.020 |
Why?
|
Neutrophils | 2 | 2016 | 3763 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2014 | 637 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 1996 | 1318 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1999 | 2426 | 0.020 |
Why?
|
Immunization | 1 | 2014 | 1218 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2007 | 11509 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1999 | 6504 | 0.020 |
Why?
|
Tissue Donors | 2 | 2010 | 2335 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2023 | 3836 | 0.020 |
Why?
|
Teaching | 1 | 2017 | 1171 | 0.020 |
Why?
|
Dysmenorrhea | 1 | 2010 | 98 | 0.020 |
Why?
|
Blotting, Western | 1 | 1996 | 5032 | 0.020 |
Why?
|
Color | 1 | 2010 | 297 | 0.020 |
Why?
|
Transcriptional Activation | 2 | 2007 | 1749 | 0.020 |
Why?
|
Promoter Regions, Genetic | 3 | 2007 | 5773 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 1999 | 3446 | 0.020 |
Why?
|
Hematopoietic System | 1 | 2007 | 110 | 0.020 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 1993 | 826 | 0.020 |
Why?
|
Myeloid Progenitor Cells | 1 | 2007 | 112 | 0.020 |
Why?
|
Transplantation Immunology | 1 | 2009 | 537 | 0.020 |
Why?
|
Fibroblasts | 1 | 1996 | 4137 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1996 | 3702 | 0.020 |
Why?
|
Mice | 6 | 2007 | 81326 | 0.020 |
Why?
|
Nuclear Proteins | 2 | 1999 | 5782 | 0.020 |
Why?
|
Vidarabine | 1 | 2007 | 336 | 0.020 |
Why?
|
DNA | 3 | 2007 | 7189 | 0.020 |
Why?
|
Autoimmunity | 1 | 2013 | 1356 | 0.020 |
Why?
|
Melphalan | 1 | 2007 | 420 | 0.020 |
Why?
|
Survival Analysis | 2 | 2009 | 10088 | 0.020 |
Why?
|
Antilymphocyte Serum | 1 | 2007 | 491 | 0.020 |
Why?
|
Neoplasms | 1 | 2014 | 22140 | 0.020 |
Why?
|
Hysterectomy | 1 | 2010 | 857 | 0.020 |
Why?
|
Signal Transduction | 2 | 1999 | 23416 | 0.020 |
Why?
|
Cell Count | 1 | 2009 | 1831 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 1993 | 1803 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 2010 | 746 | 0.010 |
Why?
|
Animals | 8 | 2010 | 168079 | 0.010 |
Why?
|
Vaccines | 1 | 1993 | 835 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2014 | 2220 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1993 | 2549 | 0.010 |
Why?
|
Smad3 Protein | 1 | 2004 | 166 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3696 | 0.010 |
Why?
|
Rabbits | 1 | 2010 | 4750 | 0.010 |
Why?
|
Child | 2 | 2022 | 80152 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2002 | 26 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2002 | 102 | 0.010 |
Why?
|
Myogenic Regulatory Factors | 1 | 2002 | 102 | 0.010 |
Why?
|
Transcription Factor AP-1 | 1 | 2004 | 318 | 0.010 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2002 | 135 | 0.010 |
Why?
|
Glucose Transporter Type 4 | 1 | 2002 | 240 | 0.010 |
Why?
|
Tunica Intima | 1 | 2004 | 458 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2002 | 286 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2008 | 1385 | 0.010 |
Why?
|
Luciferases | 1 | 2002 | 710 | 0.010 |
Why?
|
Macrophage Activation | 1 | 2004 | 552 | 0.010 |
Why?
|
Treatment Failure | 1 | 2007 | 2643 | 0.010 |
Why?
|
3T3 Cells | 1 | 2002 | 1083 | 0.010 |
Why?
|
Hyperplasia | 1 | 2004 | 1150 | 0.010 |
Why?
|
Retroviridae | 1 | 2002 | 850 | 0.010 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2004 | 630 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2010 | 6819 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2002 | 1989 | 0.010 |
Why?
|
CREB-Binding Protein | 1 | 1999 | 146 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2002 | 13402 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2002 | 2263 | 0.010 |
Why?
|
Cell Lineage | 1 | 2007 | 2548 | 0.010 |
Why?
|
Schizosaccharomyces pombe Proteins | 1 | 1999 | 178 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2002 | 17598 | 0.010 |
Why?
|
Blood Platelets | 1 | 2009 | 2477 | 0.010 |
Why?
|
Patient Care Team | 1 | 2008 | 2515 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2004 | 1963 | 0.010 |
Why?
|
Ligands | 1 | 2002 | 3264 | 0.010 |
Why?
|
Adipocytes | 1 | 2002 | 1190 | 0.010 |
Why?
|
Societies, Medical | 1 | 2008 | 3923 | 0.010 |
Why?
|
Serine | 1 | 1999 | 826 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 4567 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2004 | 3726 | 0.010 |
Why?
|
Mutagenesis | 1 | 1999 | 1226 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1993 | 10203 | 0.010 |
Why?
|
Protein Binding | 1 | 2007 | 9297 | 0.010 |
Why?
|
Fungal Proteins | 1 | 1999 | 908 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2007 | 4513 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1999 | 2740 | 0.010 |
Why?
|
Tyrosine | 1 | 1999 | 1422 | 0.010 |
Why?
|
Biological Transport | 1 | 1999 | 2080 | 0.010 |
Why?
|
Point Mutation | 1 | 1999 | 1593 | 0.010 |
Why?
|
Decision Making | 1 | 2008 | 3931 | 0.010 |
Why?
|
Models, Genetic | 1 | 2002 | 3430 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2007 | 12747 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1993 | 623 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 6180 | 0.010 |
Why?
|
Drosophila | 1 | 1999 | 1495 | 0.010 |
Why?
|
Rats | 1 | 2007 | 23704 | 0.010 |
Why?
|
Lymphocyte Depletion | 1 | 1993 | 602 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2007 | 16952 | 0.010 |
Why?
|
Binding Sites | 1 | 1999 | 5988 | 0.010 |
Why?
|
Glucose | 1 | 2002 | 4342 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1993 | 1762 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2004 | 3258 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 64681 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2008 | 5333 | 0.010 |
Why?
|
Phenotype | 1 | 2007 | 16575 | 0.010 |
Why?
|
Proteins | 1 | 2004 | 5993 | 0.000 |
Why?
|
Macrophages | 1 | 2004 | 5753 | 0.000 |
Why?
|
Cryptococcus neoformans | 1 | 1949 | 120 | 0.000 |
Why?
|
Cryptococcosis | 1 | 1949 | 103 | 0.000 |
Why?
|
Mice, Knockout | 1 | 2004 | 14392 | 0.000 |
Why?
|
Muscle, Skeletal | 1 | 2002 | 4947 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2002 | 18926 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 11733 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2004 | 22127 | 0.000 |
Why?
|
Antibodies | 1 | 1993 | 2415 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1993 | 5478 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2004 | 15637 | 0.000 |
Why?
|
Lymph Nodes | 1 | 1993 | 3461 | 0.000 |
Why?
|